Clinical Trial Update: A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C [Phase 2]

View source ↗

Summary

Phase 2 study evaluating Mericitabine in combination with Telaprevir and Peginterferon alfa-2a plus Ribavirin in participants with chronic Hepatitis C has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Mericitabine (mericitabine)
• Peginterferon alfa-2a (peginterferon alfa-2a)
• Ribavirin (ribavirin)
• Telaprevir (telaprevir)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED